Getty
As SA braces for a third Covid-19 wave, the importance of a vaccine rollout has become more pressing.
Medical fund Bonitas says it is working to ensure that it is ready to roll out the vaccine to eligible scheme members.
Its principal officer says the fund will be able to vaccinate 150 000 eligible people per day.
As South Africa braces itself for a third Covid-19 wave, the urgency of rolling out the vaccine is undeniable says Bonitas Medical Fund s principal officer, Lee Callakoppen.
Experts have warned that the country could find itself in the grip of the third wave at the end of this month or in the middle of May.
15 facts about the Covid-19 vaccine we should all know
By Lifestyle Reporter
Share
ALTHOUGH the vaccine roll-out for healthcare workers has begun, myths and misinformation continue to circulate around its development, efficacy and just how the vaccine will help manage or mitigate the spread of the virus.
We asked Lee Callakoppen, the principal officer of Bonitas Medical Fund, for 15 facts about the vaccine.
1. How does the Covid-19 vaccine work?
The Covid-19 vaccines produce protection against the disease by developing an immune response to the SARS-Cov-2 virus. The vaccine stimulates an immune response to an antigen, a molecule found on the virus and provides a supply of “memory” T- and B-lymphocytes that help to fight that virus in the future.
ResearchAndMarkets.com’s offering.
This report focuses on Medical Aid Funding, and includes information on the state and size of the sector, developments and corporate actions of its major players, and influencing factors including regulation and the effect of the coronavirus pandemic.
There are profiles of 31 companies including major administrators such as Discovery Health, Medscheme and Momentum Health, restricted schemes such as the Government Employees Medical Scheme, South African Police Service Medical Aid and Sasolmed, and open schemes such as Bestmed and Medshield.
Medical Aid Funding:
South Africa spends more on private health insurance as a percentage of total health expenditure than almost any other country. Although the sector performs a critical role in the health system, medical scheme membership remains out of the reach of over 85% of the population. Although the details remain unclear, the implementation of the National Health Insurance Fund will invariably aff
3 Min Read
JOHANNESBURG (Reuters) - Days before coronavirus vaccinations start in South Africa, medical schemes have still not agreed how and to what extent they will contribute to the cost of inoculations for people without insurance cover, industry executives told Reuters. A test tube labelled vaccine in front of an AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
South Africa is expecting its first 1 million doses of the AstraZeneca vaccine to land on Monday and will start immunising health workers from mid-February. The country has been the hardest-hit by the COVID-19 pandemic on the continent, with more than 1.4 million cases and over 43,000 deaths to date.